Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Janusmed Sex and Gender

News

The knowledge database acknowledged in American Journal of Therapeutics
In a Letter to the editor, the knowledge database Janusmed Sex and Gender is mentioned as a support to reduce the knowledge gap of sex and gender differences within evidence-based medicine. The article authors highlight the need of continuous research efforts and studies with sufficient power to generate scientific evidence about sex and gender differences in drug efficacy and safety.
11/18/2022

Women less likely to receive appropriate care for chronic kidney disease
Men were twice as likely as women to be diagnosed with chronic kidney disease within 18 months after kidney failure had been identified, according to a registry study from Karolinska Institutet which analyzed creatinine samples from individuals in Region Stockholm. Women were less likely to have their kidney function monitored, referred to a nephrologist and receive guideline-recommended medications.
08/09/2022

Reporting of sex and gender is required when publishing in Nature
The journal's new policy encourages authors to describe whether, and how, sex and gender were considered in the study design. If no sex or gender analyzes were performed, the authors will need to clarify why. Authors must also present sex-disaggregated data where relevant. This will apply to studies in humans as well as in animals and experimental studies.
06/14/2022


Read more news here!

Janusmed Sex and Gender is a knowledge database with general information on sex and gender aspects on drug treatment. The information is aimed towards healthcare personal. It is possible to search on generic names in English and trade names of drug products on the Swedish market. For detailed information on how to search, click on Search help in the blue search field. The purpose of the web site is to improve drug treatment by providing information on whether drug choice or drug dosing need to consider the patient's sex.

Please note that Janusmed Sex and Gender does not include information on teratogenic effects or compatibility with breast feeding. For this information, please consult the knowledge databases Janusmed Drugs and Birth Defects and Janusmed Drugs and Breastfeeding, respectively (in Swedish).

The Health and Medical Care Administration at Region Stockholm is responsible for the web site. The work is done in collaboration with the Department of Clinical Pharmacology, Karolinska University Hospital and Centre for Gender Medicine, Karolinska Institutet.

Engelsk flagga

Searchable substances

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Could not find any pages that start with the letter X